These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16019672)

  • 1. Role of innate and adaptive immunity in the pathogenesis of keratitis.
    Hazlett LD
    Ocul Immunol Inflamm; 2005; 13(2-3):133-8. PubMed ID: 16019672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal response to Pseudomonas aeruginosa infection.
    Hazlett LD
    Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
    Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P promotes susceptibility to Pseudomonas aeruginosa keratitis in resistant mice: anti-inflammatory mediators downregulated.
    McClellan SA; Zhang Y; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1502-11. PubMed ID: 18385069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection.
    Lighvani S; Huang X; Trivedi PP; Swanborg RH; Hazlett LD
    Eur J Immunol; 2005 May; 35(5):1567-75. PubMed ID: 15832292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.
    Willcox MD
    Optom Vis Sci; 2007 Apr; 84(4):273-8. PubMed ID: 17435510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Langerhans cells in Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Rudner XL; Barrett RP
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):189-97. PubMed ID: 11773031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
    McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD4+ T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection.
    Kwon B; Hazlett LD
    J Immunol; 1997 Dec; 159(12):6283-90. PubMed ID: 9550433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling.
    Huang X; Hazlett LD; Du W; Barrett RP
    J Immunol; 2006 Jul; 177(1):548-56. PubMed ID: 16785552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIP-1alpha regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Barrett RP; McClellan S; Hazlett LD
    J Leukoc Biol; 2001 Dec; 70(6):911-9. PubMed ID: 11739554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis.
    Berger EA; McClellan SA; Vistisen KS; Hazlett LD
    PLoS Pathog; 2013; 9(7):e1003457. PubMed ID: 23874197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.
    McClellan SA; Huang X; Barrett RP; van Rooijen N; Hazlett LD
    J Immunol; 2003 May; 170(10):5219-27. PubMed ID: 12734370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
    Huang X; Du W; Barrett RP; Hazlett LD
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.